PCSK9 inhibitors

This Trial Could Be Worth Billions to Amgen
Investopedia
Wed, 06/10/15 - 09:48 pm
Amgen
Repatha
PCSK9 inhibitors
FDA panel backs Amgen's cholesterol drug for high-risk patients
Yahoo/Reuters
Wed, 06/10/15 - 06:13 pm
FDA
Amgen
Repatha
advisory panels
PCSK9 inhibitors
Why Regeneron’s down on a positive FDA recommendation
CNBC
Wed, 06/10/15 - 02:36 pm
Regeneron
Sanofi
Praluent
FDA
advisory panels
PCSK9 inhibitors
How The New Cholesterol Drugs From Amgen And Regeneron Could Still Be Blockbusters
Forbes
Wed, 06/10/15 - 09:08 am
Amgen
Regeneron
PCSK9 inhibitors
Repatha
Praluent
Sanofi/Regeneron's PCSK9 blockbuster-in-waiting gets prelim FDA nod
BioPharma Dive
Tue, 06/9/15 - 06:33 pm
Sanofi
Regeneron
PCSK9 inhibitors
FDA
advisory panels
Praluent
PCSK9 adcomm preview: what's at stake
Medical Marketing and Media
Tue, 06/9/15 - 09:32 am
PCSK9 inhibitors
FDA
advisory panels
Sanofi
Regeneron
Amgen
Repatha
Praluent
New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels
24/7 Wall St
Sun, 06/7/15 - 10:57 am
FDA
advisory panels
Regeneron
AbbVie
Amgen
Repatha
alirocumab
PCSK9 inhibitors
The Fight Against Cholesterol Heats Up; FDA Panel Considers Drugs from Regeneron, Amgen Next Week
Barron's
Fri, 06/5/15 - 12:22 pm
FDA
advisory panels
Regeneron
Sanofi
Amgen
PCSK9 inhibitors
Praluent
For The Pricing Of New Cholesterol Lowering PCSK-9 Drugs, Does Dose Size Matter?
Forbes
Mon, 06/1/15 - 12:16 pm
PCSK9 inhibitors
drug pricing
Amgen
Sanofi
Regeneron
Pfizer
The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war
Fierce Biotech
Tue, 05/26/15 - 04:52 pm
Gilead Sciences
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
drug pricing
Repatha
Praluent
More Preliminary Signs That The New Cholesterol Drugs May Improve Outcomes
Forbes
Tue, 04/28/15 - 08:45 am
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
alirocumab
evolocumab
Amgen Has A Big Launch Coming Up
Yahoo/Benzinga
Fri, 04/17/15 - 08:43 am
Amgen
Corlanor
PCSK9 inhibitors
Pfizer Launches First Annual PCSK9 Competitive Grants Program to Advance Cardiovascular Disease Research
Yahoo
Thu, 04/9/15 - 10:05 am
Pfizer
PCSK9 inhibitors
R&D
How PCSK9 cholesterol drugs will shift pharma's pricing trends
BioPharma Dive
Thu, 03/26/15 - 09:32 am
PCSK9 inhibitors
drug pricing
New Cholesterol Meds May Lower Heart Risks, but Will They Break the Bank?
WSJ Pharmalot
Fri, 03/20/15 - 10:58 am
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
Is This a Megablockbuster Drug in the Making?
Investopedia
Wed, 03/18/15 - 08:16 am
Amgen
Repatha
PCSK9 inhibitors
Amgen, Regeneron Stocks Go Up as Drugs Bring Cholesterol Down
Forbes
Tue, 03/17/15 - 08:47 am
Amgen
Regeneron
PCSK9 inhibitors
alirocumab
evolocumab
Amgen: Looking for a Wild Card
Barron's
Tue, 03/17/15 - 08:11 am
Amgen
PCSK9 inhibitors
Regeneron
AMG-145
New Cholesterol Drugs: Highly Effective But Important Questions Remain
Forbes
Mon, 03/16/15 - 09:08 am
PCSK9 inhibitors
alirocumab
evolocumab
Amgen
Sanofi
Regeneron
Amgen scores a victory for PCSK9, halving cardio risks after one year
Fierce Biotech
Mon, 03/16/15 - 08:58 am
Amgen
PCSK9 inhibitors
evolocumab

Pages